Intelligent Bio Solutions announced that successful Australian civil construction entity, State Road Constructions has selected its proprietary Intelligent Fingerprinting Drug Screening System as its workplace drug screening solution. State Road Constructions supplies earthmoving equipment and heavy vehicle hire to large infrastructure and civil development projects across New South Wales with notable works, including Sydney’s Light Rail and Rozelle Interchange projects. The company will implement INBS‘ drug screening solution to continue meeting internal health and safety requirements and ensure compliance with policy. The system’s rapid functionality was a key feature for State Road, aligning with the company’s dedication to operational efficiency. Harry Simeonidis, President and Chief Executive Officer at Intelligent Bio Solutions, said, “State Road Construction’s adoption of our solution is an example of organizational progression toward more dignified practices and complete solutions that respect all individuals while at the same time enhancing workplace safety and efficiency. Employing our system means State Road Constructions can maintain safety while ensuring its projects comply with testing mandates. We look forward to growing the business relationship and ensuring State Road has the best outcomes using our non-invasive, efficient drug screening solution.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INBS:
- Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
- Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
- Intelligent Bio Solutions’ drug screening technology now offered in New Zealand
- Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
- Intelligent Bio adds logistics firm to Fingerprinting Drug Screening portfolio